HDAC9 and cancer: HDAC inhibitors (HDACi) mediate cancer cell death through several pathways and are able to induce apoptosis, differentiation, cells cycle arrest, inhibition of DNA repair, upregulation or reactivation of silenced tumor suppressors, downregulation of growth factors, autophagy, and control of angiogenesis [13–15].